Oasmia Pharmaceutical develops a new generation of drugs within human and veterinary oncology.
Business Model:
Revenue: $349k
Employees: 51-200
Address: Vallongatan 1
City: Uppsala
State: norrbottena län
Zip: SE-752
Country: SE
Oasmia Pharmaceutical develops a new generation of drugs within human and veterinary oncology.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/2/2010
Ticker Symbol:
OASM
Amount Raised:
$23M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2010 | Post-IPO Equity | 1 | $10.2M |
Yorkville Advisors Yorkville Advisors |
3/2019 | Post-IPO Equity | $17.7M | 4/2016 | Debt | $3.4M | 10/2015 | Post-IPO Equity | $9M | 1/2018 | Debt | $13.1M | 6/2016 | Debt | $5.2M | 10/2016 | Equity | $7.8M | 4/2018 | Private Placement | $3.1M | 3/2019 | Post-IPO Equity | $17.7M | 7/2010 | Post-IPO Equity | 1 | $10.2M |
Yorkville Advisors Yorkville Advisors Yorkville Advisors Yorkville Advisors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|